AMAG - AMAG Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 0.37
52-Week Change 3-31.08%
S&P500 52-Week Change 324.46%
52 Week High 317.39
52 Week Low 36.81
50-Day Moving Average 310.39
200-Day Moving Average 310.40

Share Statistics

Avg Vol (3 month) 3761.41k
Avg Vol (10 day) 3511.84k
Shares Outstanding 533.92M
Float 16.35M
% Held by Insiders 12.05%
% Held by Institutions 1121.21%
Shares Short (Nov 29, 2019) 414.05M
Short Ratio (Nov 29, 2019) 415.23
Short % of Float (Nov 29, 2019) 4103.16%
Short % of Shares Outstanding (Nov 29, 2019) 441.43%
Shares Short (prior month Oct 31, 2019) 413.31M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/3
Last Split Date 3Sep 26, 1991

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019


Profit Margin -88.55%
Operating Margin (ttm)-32.60%

Management Effectiveness

Return on Assets (ttm)-6.09%
Return on Equity (ttm)-46.23%

Income Statement

Revenue (ttm)326.16M
Revenue Per Share (ttm)9.54
Quarterly Revenue Growth (yoy)-31.20%
Gross Profit (ttm)230.21M
Net Income Avi to Common (ttm)-287.28M
Diluted EPS (ttm)-8.45
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)191.54M
Total Cash Per Share (mrq)5.65
Total Debt (mrq)280.46M
Total Debt/Equity (mrq)58.35
Current Ratio (mrq)1.67
Book Value Per Share (mrq)14.17

Cash Flow Statement

Operating Cash Flow (ttm)-129.82M
Levered Free Cash Flow (ttm)-85.98M